Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation × trametinib × 30 days × Clear all

Sponsor

Conditions

Melanoma 9 Multiple Myeloma 6 Hematologic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Lymphoma 3 Glioma 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Neoplasms 2 Uveal Melanoma 1 Thyroid Cancer, Papillary 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Juvenile 1 Laryngeal Neoplasms 1 Histiocytosis, Langerhans-Cell 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Erdheim-Chester Disease 1 Astrocytoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡